IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

BATTEZZATI, PIER MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 9.981
NA - Nord America 8.400
AS - Asia 6.914
SA - Sud America 730
AF - Africa 143
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 3
Totale 26.200
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.104
GB - Regno Unito 4.547
CN - Cina 2.327
SG - Singapore 2.067
IT - Italia 1.487
RU - Federazione Russa 783
DE - Germania 759
HK - Hong Kong 733
SE - Svezia 610
BR - Brasile 539
FR - Francia 450
VN - Vietnam 359
IN - India 324
TR - Turchia 284
NL - Olanda 253
KR - Corea 238
UA - Ucraina 210
IE - Irlanda 200
CA - Canada 196
FI - Finlandia 181
JP - Giappone 137
ES - Italia 120
EU - Europa 109
ID - Indonesia 101
BD - Bangladesh 83
GR - Grecia 73
DK - Danimarca 71
PL - Polonia 64
CO - Colombia 53
AR - Argentina 49
MX - Messico 46
CI - Costa d'Avorio 44
AT - Austria 32
AU - Australia 25
IQ - Iraq 25
PK - Pakistan 25
PH - Filippine 24
BE - Belgio 21
EC - Ecuador 21
SA - Arabia Saudita 21
ZA - Sudafrica 21
IL - Israele 18
MY - Malesia 18
NO - Norvegia 18
RO - Romania 17
UZ - Uzbekistan 17
PE - Perù 16
VE - Venezuela 16
AE - Emirati Arabi Uniti 15
CR - Costa Rica 15
CL - Cile 13
TH - Thailandia 13
EG - Egitto 12
PT - Portogallo 12
TW - Taiwan 12
CH - Svizzera 11
KZ - Kazakistan 11
PY - Paraguay 10
KE - Kenya 9
MA - Marocco 9
CZ - Repubblica Ceca 8
DZ - Algeria 8
HR - Croazia 8
HU - Ungheria 8
JO - Giordania 8
SK - Slovacchia (Repubblica Slovacca) 8
TN - Tunisia 8
BG - Bulgaria 7
JM - Giamaica 7
NG - Nigeria 7
OM - Oman 7
CY - Cipro 6
IR - Iran 6
NP - Nepal 6
UY - Uruguay 6
AL - Albania 5
BO - Bolivia 5
ET - Etiopia 5
HN - Honduras 5
LK - Sri Lanka 5
LV - Lettonia 5
TT - Trinidad e Tobago 5
KG - Kirghizistan 4
LY - Libia 4
PR - Porto Rico 4
SN - Senegal 4
BB - Barbados 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SC - Seychelles 3
BN - Brunei Darussalam 2
BW - Botswana 2
BY - Bielorussia 2
DJ - Gibuti 2
DO - Repubblica Dominicana 2
GL - Groenlandia 2
Totale 26.273
Salva come PNG Salva come JPEG
Città #
Southend 4.201
Houston 1.421
Singapore 1.212
Hong Kong 694
Ashburn 674
Ann Arbor 555
Milan 548
San Jose 437
Beijing 413
Chandler 411
Dallas 333
Seattle 295
Princeton 255
Wilmington 249
Council Bluffs 224
Dublin 198
Los Angeles 177
New York 153
Hefei 148
Fairfield 147
Bengaluru 136
Redmond 133
Dearborn 132
Jacksonville 130
Lauterbourg 124
Frankfurt am Main 122
Santa Clara 121
Toronto 115
Nanjing 110
Ho Chi Minh City 109
Buffalo 105
Guangzhou 104
Shanghai 100
Des Moines 98
Moscow 97
Woodbridge 95
Hanoi 91
Grafing 87
Sakarya 87
Mountain View 83
Jinan 72
Tokyo 72
Berlin 67
Cambridge 65
Boardman 60
Jakarta 60
Munich 60
Serra 60
Helsinki 59
Rome 58
São Paulo 57
Cangzhou 51
Redwood City 50
Shenyang 50
Columbus 49
Andover 47
Changsha 47
Somerville 46
Warsaw 45
London 44
Seoul 44
Abidjan 43
Bogotá 42
Tianjin 41
Hangzhou 38
The Dalles 37
Athens 35
Florence 35
Zhengzhou 35
San Diego 32
Shenzhen 32
Nanchang 30
Hebei 29
Istanbul 27
Madrid 26
Phoenix 25
San Francisco 25
Wuhan 25
Boston 24
Fuzhou 24
Saint Petersburg 24
Paris 23
Falls Church 22
Manchester 21
Naples 21
Nuremberg 21
Belo Horizonte 20
Mumbai 20
Silver Spring 20
Amsterdam 19
Chicago 19
Haiphong 19
Ningbo 19
Turin 19
Jiaxing 18
Montreal 18
Orem 18
Bitonto 17
Hamburg 17
Kunming 17
Totale 17.084
Salva come PNG Salva come JPEG
Nome #
Risk of obstructive sleep apnea with daytime sleepiness is associated with liver damage in non-morbidly obese patients with nonalcoholic Fatty liver disease 1.635
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis 962
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history 586
Effects of Age and Sex of on Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients with Primary Biliary Cholangitis 496
CA.ME.LI.A. An epidemiological study on the prevalence of cardiovascular, metabolic, liver and autoimmune diseases in Northern Italy 416
X chromosome monosomy : a common mechanism for autoimmune diseases 351
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 344
Peculiar HLA polymorphisms in Italian patients with primary biliary cirrhosis 342
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 328
Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis 305
Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status 287
Hypercholesterolaemia is not associated with early atherosclerotic lesions in primary biliary cirrhosis 280
X monosomy in female systemic lupus erythematosus 277
ABCB4 mutations in adult patients with cholestatic liver disease : impact and phenotypic expression 266
Antibodies to carbonic anhydrase II in antimitochondrial antibody-negative primary biliary cirrhosis: a negative study 264
Acute liver and renal failure during treatment with buprenorphine at therapeutic dose 259
Treatment with PEG-interferon and ribavirin for chronic hepatitis C increases neutrophil and monocyte chemotaxis 256
Uno studio longitudinale sull’incidenza di eventi cardiovascolari in una popolazione del nord Italia 253
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 250
Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis 250
Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis 249
Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis 248
Spontaneous hypoglycemia in patients with cystic fibrosis 248
Frequency of monosomy X in women with primary biliary cirrhosis 246
T-cell receptor polymorphism in primary biliary cirrhosis 245
Sieroepidemiologia delle epatiti virali a trasmissione enterica (HAV e HEV) in Italia: progetto CAMELIA 241
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival 234
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 234
Infermieristica clinica in medicina interna 230
Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis 230
Collecting stories of illness experience. An undergraduate medical curriculum to develop connectedness and togetherness with patients 229
Reduced insulin secretion during OGTT is tightly related to subsequent development of cystic fibrosis related diabetes 226
Severe azathioprine-induced liver injury 22 months after initiation of treatment 224
Seroepidemiology of HEV and HAV in two populations with different socio-economic levels and hygienic/sanitary conditions 221
Insulin secretory defects identified from OGTT modelling are related to subsequent diabetes and worse pulmonary function in CF patients 220
Identification of insulin secretory defects and insulin resistance during oral glucose tolerance test in a cohort of cystic fibrosis patients 220
[Reynolds syndrome. First Italian epidemiologic data] 220
Blood fetal microchimerism in primary biliary cirrhosis 215
Genetic variants of the endothelial nitric oxide synthase in patients with primary biliary cirrhosis: Association with disease severity 213
Synergistic effects of glucose tolerance and BMI on cardiovascular events and all-cause mortality in a healthy population. CA.ME.LI.A study 7 year follow-up 211
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 206
Ursodeoxycholic and tauro-ursodeoxycholic acids for the treatment of primary biliary cirrhosis: a pilot crossover study 203
EFFECT OF EARLY DERANGEMENTS IN GLUCOSE TOLERANCE MECHANISMS ON THE NUTRITIONAL STATUS AND RESPIRATORY FUNCTION OF CYSTIC FIBROSIS PATIENTS 199
Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction 199
Incidence and Impact of Decompensating Events in Primary Biliary Cirrhosis : Results of an International Follow Up Study of 3030 Patients 199
Insulin secretion, nutritional status and respiratory function in cystic fibrosis patients with normal glucose tolerance 198
Age- and sex-dependent distribution of OGTT-related variables in a population of cystic fibrosis patients 198
Liver involvement in cystic fibrosis : primary organ damage or innocent bystander? 196
The Relationship of Glucose Intolerance/Diabetes and Overweight/Obesity with Sphingolipidoma Alterations 195
La formazione alle soft skills nel Corso di laurea in Medicina : uno studio qualitativo sulle scritture riflessive di un campione di studenti 195
Effects of a preparation containing a standardized ginseng extract combined with trace elements and multivitamins against hepatotoxin-induced chronic liver disease in the elderly 193
Vaccines in the 21st century: the genetic response and the innocent bystander 187
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy 185
PBC screen : an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis 184
Sustained response to combination therapy in patients with chronic hepatitis C who failed to respond to interferon 182
Role of ABCB4 gene mutations in hepatobiliary diseases of the adult : the experience of a liver Unit in Milan 178
Inadequate dietary intake but not renal tubular acidosis is associated with bone demineralization in primary biliary cirrhosis 178
Heart rate variability and early recurrence of atrial fibrillation after electrical cardioversion 178
Antibodies to hepatitis C virus in primary biliary cirrhosis 178
Caratterizzazione della "diabesità" in una popolazione del nord Italia: un'analisi epidemiologica 177
Intraductal ultrasound for the evaluation of patients with biliary strictures and no abdominal mass on computed tomography 177
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls 175
Prognostic value of C-reactive protein in patients with stress induced myocardial ischemia 175
Is autoimmunity a matter of sex? 175
Role of ABCB4 gene in liver diseases 174
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial 173
A longitudinal study on the incidence of cardiovascular events in a population of Northern Italy 172
Rischio clinico da farmaci 168
Which images do medical students draw to discuss their early clinical experience, in reflection meetings? 168
Learning to grasp the emotional dimensions of clinical practice and their powerful meaning : a study on how medical students’ report patients’ grief in their reflective writings 167
Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis 163
Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome 162
Ursodeoxycholic acid for liver disease associated to cystic fibrosis: long-term follow-up of patients enrolled in the Italian multicenter trial 161
Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients 158
Primary biliary cirrhosis is not an additional risk factor for bone loss in women receiving regular calcium and vitamin D supplementation. A controlled longitudinal study 155
Clinical features and management of primary biliary cirrhosis 155
Effect of different doses of ursodeoxycholic acid in chronic liver disease 155
Role of Lipoylation of the Immunodominant Epitope of Pyruvate Dehydrogenase Complex : Toward a Peptide-Based Diagnostic Assay for Primary Biliary Cirrhosis 154
Serum anti-phospholipid antibody prevalence and cardiovascular significance in the general population of the camelia study 154
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 154
Ursodeoxycholic acid for chronic liver diseases 150
Lack of association between circulating HCV-RNA and anti-HCV positivity in primary biliary cirrhosis 150
Acupuncture for paroxysmal and persistent atrial fibrillation : An effective non-pharmacological tool? 148
Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis 144
Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration 143
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study 141
Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies 140
Prognostic value of N-myc immunoreactivity in medullary thyroid carcinoma 139
Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome 138
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis 137
Primary Biliary Cholangitis at a Young Age : Clinical Characteristics and Prognosis 137
Increase in age at diagnosis of Primary Biliary Cholangitis over the last 40 years 132
MMP-1 and MMP-3 polymorphism and arrhythmia recurrence after electrical cardioversion in patients with persistent atrial fibrillation 131
Novel soy germ pasta improves endothelial function, blood pressure, and oxidative stress in patients with type 2 diabetes 131
Efficacy of acupuncture in preventing atrial fibrillation recurrences after electrical cardioversion 130
Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study 130
Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial 129
Hepatitis C virus testing in primary biliary cirrhosis 129
Storie di bevitori passivi: un progetto di formazione dei medici per favorire l'inclusione e la tutela del diritto alla salute 129
Alterazioni dello sfingolipidoma circolante in una popolazione selezionata di una cittadina del Nord Italia: Relazione con intolleranza glucidica/diabete e sovrappeso/obesità 128
Totale 22.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 67.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.159
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021619 0 0 0 0 0 0 0 0 0 0 488 131
2021/20221.974 172 151 119 178 122 123 151 105 217 188 157 291
2022/20231.754 226 154 125 204 200 301 50 96 158 92 91 57
2023/20241.472 66 157 126 94 300 87 81 103 43 79 157 179
2024/20253.633 160 327 152 388 258 186 198 342 228 365 334 695
2025/20267.078 671 493 893 556 768 519 997 471 763 542 405 0
Totale 27.341